Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis

被引:104
作者
Flynn, Michelle C. [1 ,2 ]
Kraakman, Michael J. [1 ,4 ,5 ]
Tikellis, Christos [3 ]
Lee, Man K. S. [1 ,2 ]
Hanssen, Nordin M. J. [6 ]
Kammoun, Helene L. [1 ,2 ]
Pickering, Raelene J. [3 ]
Dragoljevic, Dragana [1 ]
Al-Sharea, Annas [1 ]
Barrett, Tessa J. [7 ]
Hortle, Fiona [1 ]
Byrne, Frances L. [8 ]
Olzomer, Ellen [8 ]
McCarthy, Domenica A. [9 ]
Schalkwijk, Casper G. [6 ]
Forbes, Josephine M. [9 ]
Hoehn, Kyle [8 ]
Makowski, Liza [10 ]
Lancaster, Graeme I. [1 ,2 ]
El-Osta, Assam [3 ,11 ,12 ,13 ,14 ]
Fisher, Edward A. [7 ]
Goldberg, Ira J. [7 ]
Cooper, Mark E. [3 ]
Nagareddy, Prabhakara R. [15 ]
Thomas, Merlin C. [3 ]
Murphy, Andrew J. [1 ,2 ,16 ]
机构
[1] Baker Heart & Diabet Inst, Haematopoiesis & Leukocyte Biol, Div Immunometab, Melbourne, Vic, Australia
[2] Monash Univ, Dept Immunol, Melbourne, Vic, Australia
[3] Monash Univ, Diabet, Melbourne, Vic, Australia
[4] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY USA
[5] Columbia Univ, Dept Med, New York, NY USA
[6] Maastricht Univ, Dept Internal Med, CARIM, Sch Cardiovasc Dis, Maastricht, Netherlands
[7] NYU, Div Cardiol, Sch Med, New York, NY 10003 USA
[8] NYU, Div Endocrinol Diabet & Metab, Sch Med, New York, NY 10003 USA
[9] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia
[10] Univ Queensland, Glycat & Diabet Grp, Mater Res Inst, Translat Res Inst, Brisbane, Qld, Australia
[11] Univ Tennessee, Ctr Hlth Sci, Dept Med, Div Hematol & Oncol, Memphis, TN 38163 USA
[12] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China
[13] Chinese Univ Hong Kong, Hong Kong Inst Diabet & Obes, Prince Wales Hosp, Hong Kong, Peoples R China
[14] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China
[15] Ohio State Univ, Cardiac Surg, Dept Surg, Columbus, OH 43210 USA
[16] Univ Melbourne, Dept Physiol, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
atherosclerosis; diabetes mellitus; inflammation; metabolism; stem cells; INSULIN-INDUCED HYPOGLYCEMIA; HEMATOPOIETIC STEM; DIABETES-MELLITUS; EATING PATTERNS; GLUCOSE; DISEASE; BINDING; MONOCYTOSIS; MACROPHAGES; RECEPTOR;
D O I
10.1161/CIRCRESAHA.120.316653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Treatment efficacy for diabetes mellitus is largely determined by assessment of HbA1c (glycated hemoglobin A1c) levels, which poorly reflects direct glucose variation. People with prediabetes and diabetes mellitus spend >50% of their time outside the optimal glucose range. These glucose variations, termed transient intermittent hyperglycemia (TIH), appear to be an independent risk factor for cardiovascular disease, but the pathological basis for this association is unclear. Objective: To determine whether TIH per se promotes myelopoiesis to produce more monocytes and consequently adversely affects atherosclerosis. Methods and Results: To create a mouse model of TIH, we administered 4 bolus doses of glucose at 2-hour intervals intraperitoneally once to WT (wild type) or once weekly to atherosclerotic prone mice. TIH accelerated atherogenesis without an increase in plasma cholesterol, seen in traditional models of diabetes mellitus. TIH promoted myelopoiesis in the bone marrow, resulting in increased circulating monocytes, particularly the inflammatory Ly6-C(hi)subset, and neutrophils. Hematopoietic-restricted deletion ofS100a9,S100a8, or its cognate receptorRageprevented monocytosis. Mechanistically, glucose uptake via GLUT (glucose transporter)-1 and enhanced glycolysis in neutrophils promoted the production of S100A8/A9. Myeloid-restricted deletion ofSlc2a1(GLUT-1) or pharmacological inhibition of S100A8/A9 reduced TIH-induced myelopoiesis and atherosclerosis. Conclusions: Together, these data provide a mechanism as to how TIH, prevalent in people with impaired glucose metabolism, contributes to cardiovascular disease. These findings provide a rationale for continual glucose control in these patients and may also suggest that strategies aimed at targeting the S100A8/A9-RAGE (receptor for advanced glycation end products) axis could represent a viable approach to protect the vulnerable blood vessels in diabetes mellitus.
引用
收藏
页码:877 / 892
页数:16
相关论文
共 57 条
[1]   Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice [J].
Abram, Clare L. ;
Roberge, Gray L. ;
Hu, Yongmei ;
Lowell, Clifford A. .
JOURNAL OF IMMUNOLOGICAL METHODS, 2014, 408 :89-100
[2]   Chronic sympathetic driven hypertension promotes atherosclerosis by enhancing hematopoiesis [J].
Al-Sharea, Annas ;
Lee, Man K. S. ;
Whillas, Alexandra ;
Michell, Danielle L. ;
Shihata, Waled A. ;
Nicholls, Alyce J. ;
Cooney, Olivia D. ;
Kraakman, Michael J. ;
Veiga, Camilla Bertuzzo ;
Jefferis, Ann-Maree ;
Jackson, Kristy ;
Nagareddy, Prabhakara R. ;
Lambert, Gavin ;
Wong, Connie H. Y. ;
Andrews, Karen L. ;
Head, Geoff A. ;
Chin-Dusting, Jaye ;
Murphy, Andrew J. .
HAEMATOLOGICA, 2019, 104 (03) :456-467
[3]   SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr-/- type 1 diabetic mice [J].
Al-Sharea, Annas ;
Murphy, Andrew J. ;
Huggins, L. A. ;
Hu, Y. ;
Goldberg, Ira J. ;
Nagareddy, Prabhakara R. .
ATHEROSCLEROSIS, 2018, 271 :166-176
[4]  
American Diabetes Association, 2017, Clin Diabetes, V35, P5, DOI 10.2337/cd16-0067
[5]   BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis [J].
Bagger, Frederik Otzen ;
Sasivarevic, Damir ;
Sohi, Sina Hadi ;
Laursen, Linea Goricke ;
Pundhir, Sachin ;
Sonderby, Casper Kaae ;
Winther, Ole ;
Rapin, Nicolas ;
Porse, Bo T. .
NUCLEIC ACIDS RESEARCH, 2016, 44 (D1) :D917-D924
[6]   Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance - The Australian diabetes, obesity, and lifestyle study (AusDiab) [J].
Barr, Elizabeth L. M. ;
Zimmet, Paul Z. ;
Welborn, Timothy A. ;
Jolley, Damien ;
Magliano, Dianna J. ;
Dunstan, David W. ;
Cameron, Adrian J. ;
Dwyer, Terry ;
Taylor, Hugh R. ;
Tonkin, Andrew M. ;
Wong, Tien Y. ;
McNeil, John ;
Shaw, Jonathan E. .
CIRCULATION, 2007, 116 (02) :151-157
[7]   Diabetes-mediated myelopoiesis and the relationship to cardiovascular risk [J].
Barrett, Tessa J. ;
Murphy, Andrew J. ;
Goldberg, Ira J. ;
Fisher, Edward A. .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2017, 1402 (01) :31-42
[8]   Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - A mechanism for amplification of inflammatory responses [J].
Basta, G ;
Lazzerini, G ;
Massaro, M ;
Simoncini, T ;
Tanganelli, P ;
Fu, CF ;
Kislinger, T ;
Stern, DM ;
Schmidt, AM ;
De Caterina, R .
CIRCULATION, 2002, 105 (07) :816-822
[9]   Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management [J].
Beckman, JA ;
Creager, MA ;
Libby, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19) :2570-2581
[10]   Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides [J].
Bjork, Per ;
Bjork, Anders ;
Vogl, Thomas ;
Stenstrom, Martin ;
Liberg, David ;
Olsson, Anders ;
Roth, Johannes ;
Ivars, Fredrik ;
Leanderson, Tomas .
PLOS BIOLOGY, 2009, 7 (04) :800-812